Antoni Ribas

Also affiliated with University of California, Los Angeles, Parker Institute for Cancer Immunotherapy, USC Norris Comprehensive Cancer Center, Comprehensive Blood & Cancer Center, UCLA Jonsson Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.3Author DataRank

Indexed papers

10in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 10 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

Nature Genetics(2023)10.1038/s41588-022-01268-9

Top 16%

1.3DataRank

Top 16%59 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera +20 more

Papers

Driven by 99 papers — median percentile 0. Top paper: “Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial”.

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

The Lancet(2015)10.1016/s0140-6736(15)60898-4

N/A

13.9DataRank · unranked

1394 citations

Daniil Stroyakovskiy, Helen Gogas, Evgeny Levchenko, Filippo de Braud, James Larkin +29 more

Multiple early factors anticipate post-acute COVID-19 sequelae

Cell(2022)10.1016/j.cell.2022.01.014

N/A

12.9DataRank · unranked

1211 citations

Dan Yuan, Daniel Chen, Raymond T. Ng, Kai Wang, Jongchan Choi +68 more

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Cell(2017)10.1016/j.cell.2017.01.017

N/A

12.7DataRank · unranked

5568 citations

Siwen Hu-Lieskovan, Jennifer A. Wargo, Antoni Ribas, Padmanee Sharma

Single-cell analysis tools for drug discovery and development

Nature Reviews Drug Discovery(2016)10.1038/nrd.2015.16

N/A

10.9DataRank · unranked

486 citations

Antoni Ribas, Paul S. Mischel, James R. Heath

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2020)10.1016/j.ccell.2020.08.005

N/A

9.5DataRank · unranked

393 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo +31 more

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

New England Journal of Medicine(2023)10.1056/nejmoa2211437

N/A

6.5DataRank · unranked

846 citations

Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John Hyngstrom +48 more

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial—ECOG-ACRIN EA6134.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.36_suppl.356154

N/A

5.7DataRank · unranked

111 citations

Sandra J. Lee, Bartosz Chmielowski, Antoni Ribas, Ahmad A. Tarhini, Thach‐Giao Truong +9 more

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Journal of Clinical Oncology(2022)10.1200/jco.22.01763

N/A

5.4DataRank · unranked

446 citations

Sandra J. Lee, Bartosz Chmielowski, Ahmad A. Tarhini, Gary I. Cohen, Thach‐Giao Truong +31 more

Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study

The Lancet Oncology(2021)10.1016/s1470-2045(20)30726-9

N/A

4.9DataRank · unranked

94 citations

Jennifer Wiggins, Broderick C. Corless, Georgina V. Long, Keith T. Flaherty, Dirk Schadendorf +12 more

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02498-y

N/A

4.8DataRank · unranked

171 citations

Shay Bellasea, Kari Kendra, Nikhil I. Khushalani, Katie M. Campbell, Philip O. Scumpia +28 more

Non-viral precision T cell receptor replacement for personalized cell therapy

Nature(2022)10.1038/s41586-022-05531-1

N/A

4.1DataRank · unranked

281 citations

Kyle Jacoby, Daniela A. Bota, Theresa Hunter, Zheng Pan, Eric Stawiski +49 more

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.010

N/A

3.9DataRank · unranked

100 citations

Wen-Jen Hwu, Omid Hamid, Antoni Ribas, Jeffrey S. Weber, Adil Daud +18 more

Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy

Cancer Cell(2021)10.1016/j.ccell.2021.07.023

N/A

3.9DataRank · unranked

135 citations

Sixue Liu, Zhentao Yang, Alain P. Algazi, Shirley H. Lomeli, Yan Wang +16 more

Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist

Nature Communications(2020)10.1038/s41467-019-12901-3

N/A

2.5DataRank · unranked

96 citations

Justin D. Saco, Felix B. Salazar, Jennifer Tsoi, Paige Krystofinski, Cristina Puig-Saus +16 more

Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100139

N/A

2.3DataRank · unranked

79 citations

Daniel C. Bruhm, Noushin Niknafs, James R. White, Xiaoshan M. Shao, John-William Sidhom +19 more

Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma

Cancer Cell(2023)10.1016/j.ccell.2023.03.010

N/A

2.2DataRank · unranked

82 citations

Meelad Amouzgar, Shannon M. Pfeiffer, Timothy R. Howes, Egmidio Medina, Michael J. Travers +14 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2021)10.1016/j.ccell.2020.11.015

N/A

1.9DataRank · unranked

53 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Megan Wind-Rotolo +31 more

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Nature(2014)10.1038/nature13954

N/A

1.3DataRank · unranked

6579 citations

Christina L. Harview, Jennifer H. Yearley, I. Peter Shintaku, Emma J. M. Taylor, Lidia Robert +28 more

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

Nature Genetics(2023)10.1038/s41588-022-01268-9

Top 16%

1.3DataRank

Top 16%59 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera +20 more

Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9501

N/A

1.3DataRank · unranked

18 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Teresa M. Petrella +15 more

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

New England Journal of Medicine(2014)10.1056/nejmoa1406037

N/A

1.1DataRank · unranked

1883 citations

Daniil Stroyakovskiy, Helen Gogas, Evgeny Levchenko, Filippo de Braud, James Larkin +30 more

Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence

Cancer Research(2014)10.1158/0008-5472.can-13-2625

N/A

0.862DataRank · unranked

312 citations

Christine A. Pratilas, Alexis M. Jones, Ricardo Ramirez, Helen Won, Cailian Liu +14 more

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

Cell(2022)10.1016/j.cell.2022.06.007

N/A

0.807DataRank · unranked

216 citations

Johannes C. Melms, Amit Dipak Amin, Yiping Wang, Lindsay Caprio, Alcida Karz +54 more

Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy

Nature(2023)10.1038/s41586-023-05787-1

N/A

0.798DataRank · unranked

203 citations

Barbara Sennino, Songming Peng, Clifford L. Wang, Zheng Pan, Benjamin Yuen +51 more

Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006930

N/A

0.793DataRank · unranked

18 citations

Arun S. Singh, Cole W. Peters, Begoña Comı́n-Anduix, Beata Berent-Maoz, Mignonette H. Macabali +7 more

T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome

Nature Reviews Drug Discovery(2023)10.1038/s41573-023-00809-z

N/A

0.757DataRank · unranked

155 citations

Smita S. Chandran, Brian M. Baker, Sergio A. Quezada, Antoni Ribas, Christopher A. Klebanoff

A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0145

N/A

0.752DataRank · unranked

19 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

Science Translational Medicine(2020)10.1126/scitranslmed.abb0152

N/A

0.737DataRank · unranked

135 citations

Mito Tariveranmoshabad, Kevin Hakimi, Sarah Kremer, Katie M. Campbell, Juan M. Funes +13 more

Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity

Cell Reports(2024)10.1016/j.celrep.2024.114289

N/A

0.703DataRank · unranked

22 citations

Joo-Won Seo, Manash K. Paul, Keisuke S. Iwamoto, Allison E. Daly, An‐Chieh Feng +10 more

Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line

Nature Communications(2020)10.1038/s41467-020-15956-9

N/A

0.701DataRank · unranked

106 citations

Melissa E. Ko, Hanjun Cheng, Ronghui Zhu, Min Xue, Jessica K. Wang +18 more

PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma

Nature Communications(2020)10.1038/s41467-020-19810-w

N/A

0.675DataRank · unranked

89 citations

Alain P. Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael S. Gordon +10 more

A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers

Cancer(2024)10.1002/cncr.35200

N/A

0.612DataRank · unranked

12 citations

James Moon, Christopher D. Lao, Bartosz Chmielowski, Kari Kendra, Karl D. Lewis +12 more

IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2221116120

N/A

0.596DataRank · unranked

52 citations

John W. Phillips, Beatrice Zhang, Miyako Noguchi, Eric Kutschera, Jami McLaughlin +21 more

Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.30.016931

N/A

0.593DataRank · unranked

51 citations

Gabriela Steiner, Daniel K. Wells, Antoni Ribas, Anusha Kalbasi, Katie M. Campbell

Clonally expanded, thyrotoxic effector CD8 + T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis

Science Translational Medicine(2023)10.1126/scitranslmed.adg0675

N/A

0.571DataRank · unranked

44 citations

Zikang Zhou, Aline T. Hoang, Nicole Huang, Jessica Ortega, Lauren N Scott +11 more

Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity

Journal of Clinical Investigation(2022)10.1172/jci160852

N/A

0.561DataRank · unranked

41 citations

Khalid Rashid, Thuc Le, Suwen Li, Hailey R. Lee, Vincent Lok +20 more

Antitumor Immune Responses in B2M -Deficient Cancers

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0139

N/A

0.546DataRank · unranked

37 citations

Mildred Galvez, Gabriel Abril-Rodríguez, Katie M. Campbell, Egmidio Medina, Agustin Vega-Crespo +4 more

Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma

Cancer(2024)10.1002/cncr.35587

N/A

0.539DataRank · unranked

9 citations

James Moon, T. Vincent, John P. Fruehauf, Lawrence E. Flaherty, Martin J. Bury +8 more

Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma

Cancer Cell(2025)10.1016/j.ccell.2025.01.009

N/A

0.524DataRank · unranked

32 citations

Mouadh Benamar, Jihye Park, Haley E. Sax, Giacomo Oliveira, Alice Bosma-Moody +10 more

Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0850

N/A

0.524DataRank · unranked

32 citations

James H. Doroshow, Susan Galbraith, Antoni Ribas, Paul G. Kluetz, Richard Pazdur +2 more

Computational prediction of MHC anchor locations guides neoantigen identification and prioritization

Science Immunology(2023)10.1126/sciimmunol.abg2200

N/A

0.500DataRank · unranked

27 citations

Joshua F. McMichael, Michelle Becker‐Hapak, Onyinyechi C. Onyeador, Rico Buchli, Ethan McClain +20 more

Neoadjuvant PD-1 blockade in patients with resectable desmoplastic melanoma (SWOG 1512).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9502

N/A

0.464DataRank · unranked

21 citations

James Moon, Zeynep Eroglu, Siwen Hu‐Lieskovan, William E. Carson, David A. Wada +15 more

Autoantibody Landscape in Patients with Advanced Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1966

N/A

0.457DataRank · unranked

20 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +26 more

Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects

PLoS ONE(2021)10.1371/journal.pone.0252597

N/A

0.442DataRank · unranked

18 citations

Yining Liu, Lu Sun, Willy Hugo, Robert Dimatteo, Rong Huang +10 more

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review

Cancers(2023)10.3390/cancers15092561

N/A

0.396DataRank · unranked

13 citations

Arish Noor, Mahati Paravathaneni, Ibrahim Yassine, Sandra J. Lee, Megan Othus +7 more

Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004190

N/A

0.373DataRank · unranked

11 citations

Maneesha Thaker, Egmidio Medina, Anusha Kalbasi, Arun S. Singh, Antoni Ribas +2 more

Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny

Nature Communications(2025)10.1038/s41467-025-60816-z

N/A

0.281DataRank · unranked

4 citations

Nataly Naser Al Deen, Cole W. Peters, Begoña Comı́n-Anduix, Egmidio Medina, Cristina Puig-Saus +28 more

Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1

10.1101/2025.04.01.646202

N/A

0.269DataRank · unranked

5 citations

Heini M. Natri, Yuqi Zhao, Shengchao Xu, Maryam Aftabizadeh, Begonya Comin-Anduix +18 more

Heterogeneous immunological recovery trajectories revealed in post-acute COVID-19

medRxiv(2021)10.1101/2021.03.19.21254004

N/A

0.234DataRank · unranked

3 citations

Dan Yuan, Daniel Chen, Kai Wang, Jongchan Choi, Chengzhen L. Dai +51 more

S1801: A randomized trial of adjuvant versus neoadjuvant pembrolizumab for melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps9585

N/A

0.208DataRank · unranked

3 citations

Megan Othus, James Moon, Michael T. Tetzlaff, Elizabeth I. Buchbinder, Vernon K. Sondak +9 more

Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor Efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.19.476844

N/A

0.208DataRank · unranked

3 citations

Anushi Y. Patel, Willy Hugo, Trevor E. Angell, Mandy I. Cheng, Marissa S. Pioso +12 more

Multi-modal single-cell and whole-genome sequencing of minute, frozen specimens to propel clinical applications

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.13.480272

N/A

0.208DataRank · unranked

3 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Patricia Ho +15 more

Early quality of life (QOL) and symptom analysis from the DREAMseq phase III randomized control trial of combination immunotherapy versus targeted therapy in patients (pts) with BRAF-mutant metastatic melanoma (MM) (ECOG-ACRIN EA6134).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9559

N/A

0.165DataRank · unranked

2 citations

Yue Zheng, Michael B. Atkins, Bartosz Chmielowski, Ahmad A. Tarhini, Thach‐Giao Truong +14 more

Clonally-Expanded, Thyrotoxic Autoimmune Mediator CD8 + T cells Driven by IL21 Contribute to Checkpoint Inhibitor Thyroiditis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.18.517398

N/A

0.104DataRank · unranked

1 citations

Zikang Zhou, Aline T. Hoang, Nicole Huang, Jessica Ortega, Lauren N Scott +11 more

Granulomatous and sarcoid-like immune related adverse events (irAEs) in melanoma patients following CTLA4 blockade adjuvant therapy: An analysis of 1670 high-risk patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9582

N/A

0.104DataRank · unranked

1 citations

Ibrahim Yassine, Sandra J. Lee, Megan Othus, James Moon, John M. Kirkwood +5 more

S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps10090

N/A

0.104DataRank · unranked

1 citations

Megan Othus, James Moon, Michael T. Tetzlaff, Elizabeth I. Buchbinder, Vernon K. Sondak +8 more

Association of prior immune checkpoint blockade (ICB) with longer progression-free survival (PFS) in patients treated with intermittent versus continuous dabrafenib and trametinib: A post-hoc analysis of S1320.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10039

N/A

0.104DataRank · unranked

1 citations

Megan Othus, Adil Daud, Janice M. Mehnert, Thach‐Giao Truong, Robert M. Conry +15 more

RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets

Trends in Pharmacological Sciences(2021)10.1016/j.tips.2021.01.006

N/A

0DataRank · unranked

60 citations

Kathryn E. Kadash-Edmondson, Robert Wang, John W. Phillips, Song Liu, Antoni Ribas +4 more

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1141

N/A

0DataRank · unranked

102 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100449

N/A

0DataRank · unranked

104 citations

Yang Zhou, Kwang Gi Kim, Yanni Zhu, Feiyang Ma, Jiaji Yu +24 more

Optimizing nucleic acid extraction and transcriptome evaluation from low-input, fixed clinical samples

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.02.122150

N/A

0DataRank · unranked

0 citations

Egmidio Medina, Ignacio Baselga-Carretero, Yaroslav Teper, Rangasamy P. Elumalai, Raymond J. Miller +15 more

Clinical outcomes in patients with BRAFV600 mutant melanoma and undetectable circulating tumor DNA treated with dabrafenib and trametinib.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10059

N/A

0DataRank · unranked

0 citations

Megan Othus, Benjamin Newell Voorhies, Kari Kendra, Shaker R. Dakhil, Amy Harker-Murray +6 more

Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing

Briefings in Bioinformatics(2023)10.1093/bib/bbad220

N/A

0DataRank · unranked

18 citations

Theodore S. Nowicki, Katie M. Campbell, Mohammad Vahed, Dandan Peng, Yiting Meng +13 more

Autoantibody landscape of advanced prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.02.074575

N/A

0DataRank · unranked

0 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +25 more

Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0577

N/A

0DataRank · unranked

4 citations

Cole W. Peters, Crystal Quiros, Conner K. Kidd, Moe Kawakami, Alexandra M. Klomhaus +8 more

Data from PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression

(2023)10.1158/0008-5472.c.6502911.v1

N/A

0DataRank · unranked

0 citations

Yun Xiang, Vito W. Rebecca, Ethan V. Abel, Y. Ann Chen, A. Cecilia Munko +11 more

Supplementary Data from Immunotherapy Resistance by Inflammation-Induced Dedifferentiation

Figshare(2023)10.1158/2159-8290.22532776.v1

Top 100%

0DataRank

Top 100%0 citations

Yeon Joo Kim, Lídia Robert, Jennifer Tsoi, Begoña Comı́n-Anduix, Beata Berent-Maoz +6 more

Supplementary Data from Immunotherapy Resistance by Inflammation-Induced Dedifferentiation

(2023)10.1158/2159-8290.22532776

Top 100%

0DataRank

Top 100%0 citations

Yeon Joo Kim, Lídia Robert, Jennifer Tsoi, Begoña Comı́n-Anduix, Beata Berent-Maoz +6 more

Data from CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

(2023)10.1158/2159-8290.c.6549963

N/A

0DataRank · unranked

0 citations

Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent +21 more

Data from Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

(2023)10.1158/2159-8290.c.6549583.v1

N/A

0DataRank · unranked

0 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Supplementary Table 5 from Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade

(2023)10.1158/2767-9764.22545378

N/A

0DataRank · unranked

0 citations

Davis Y. Torrejon, Daniel Karin, Katie M. Campbell, Egmidio Medina, Justin D. Saco +9 more

Supplementary Table S2 from A pilot study of neoadjuvant nivolumab, ipilimumab and intralesional oncolytic virotherapy for HER2-negative breast cancer

(2023)10.1158/2767-9764.23791808

Top 100%

0DataRank

Top 100%0 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

Data from A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

(2023)10.1158/2767-9764.c.6762524

N/A

0DataRank · unranked

0 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer

Research Square(2023)10.21203/rs.3.rs-3413673/v1

N/A

0DataRank · unranked

0 citations

Daniel Chen, Jingyi Xie, Jongchan Choi, Raymond T. Ng, Rongyu Zhang +13 more

CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes

Nature Communications(2024)10.1038/s41467-024-45221-2

N/A

0DataRank · unranked

58 citations

Justin D. Saco, Edurne Mugarza, Aleida Pujol, Jeffrey Chokry, Clement Ng +15 more

Computational prediction of MHC anchor locations guide neoantigen identification and prioritization

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.08.416271

N/A

0DataRank · unranked

1 citations

Joshua F. McMichael, Michelle Becker‐Hapak, Onyinyechi C. Onyeador, Rico Buchli, Ethan McClain +20 more

Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer

Cell Reports(2024)10.1016/j.celrep.2024.113872

N/A

0DataRank · unranked

12 citations

Jingyi Xie, Jongchan Choi, Raymond T. Ng, Rongyu Zhang, Sarah Li +13 more

A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data

Bioinformatics(2024)10.1093/bioinformatics/btae425

N/A

0DataRank · unranked

6 citations

Katie M. Campbell, Antoni Ribas, Michael C. Wu, Sarah Samorodnitsky

A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.08.584117

N/A

0DataRank · unranked

3 citations

Katie M. Campbell, Antoni Ribas, Michael C. Wu, Sarah Samorodnitsky

Trying for a BRAF Slam Dunk

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0231

N/A

0DataRank · unranked

3 citations

Roger S. Lo, Antoni Ribas

Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti–PD-1 Treatment-Naïve Advanced Melanoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0987

N/A

0DataRank · unranked

5 citations

Mohammed Milhem, Christopher Hoimes, Asim Amin, Cristopher Lao, Robert M. Conry +17 more

Whole-Proteome Screening and Multi-Modal Profiling of Antigen-Specific CD4+ T Cells at Single-Cell Resolution

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.21.649828

N/A

0DataRank · unranked

0 citations

Qi Jin, Michaela McKasson, Jongchan Choi, Vanessa Gutiérrez, Conor Brennan +35 more

Neoadjuvant PD-1 blockade: a new treatment option for patients with early-stage mismatch repair deficient solid tumors

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013061

N/A

0DataRank · unranked

0 citations

Antoni Ribas, Kristin G. Anderson

High-throughput identification and analysis of antigen-specific CD4+ T cells 4384

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.2075

N/A

0DataRank · unranked

0 citations

Qi Jin, Michaela McKasson, Vanessa Gutiérrez, Conor Brennan, Jongchan Choi +9 more

Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0300

N/A

0DataRank · unranked

17 citations

Colin Farrell, Marco Morselli, Liudmilla Rubbi, Katie M. Campbell, Mignonette H. Macabali +5 more

Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1409

N/A

0DataRank · unranked

148 citations

Gabriel Abril-Rodríguez, Ameya S. Champhekar, Jennifer Tsoi, Katie M. Campbell, Anusha Kalbasi +16 more

Precise T cell recognition programs designed by transcriptionally linking multiple receptors

Science(2020)10.1126/science.abc6270

N/A

0DataRank · unranked

157 citations

Greg M. Allen, Devan H Shah, Igal S. Sterin, Ki H. Kim, Vivian García +8 more

Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy

The Journal of Immunology(2022)10.4049/jimmunol.2200244

N/A

0DataRank · unranked

48 citations

Mandy I. Cheng, Anushi Y. Patel, Aline T. Hoang, Natalie Yakobian, Michael Astourian +9 more

Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells

Nature Communications(2020)10.1038/s41467-020-18376-x

N/A

0DataRank · unranked

173 citations

Yapeng Su, Chenxi Qian, Dan Yuan, Kun Miao, Dongkwan Lee +7 more

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0964

N/A

0DataRank · unranked

102 citations

Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent +21 more

Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade

Cancer Research Communications(2022)10.1158/2767-9764.crc-21-0133

N/A

0DataRank · unranked

19 citations

Davis Y. Torrejon, Daniel Karin, Katie M. Campbell, Egmidio Medina, Justin D. Saco +9 more

Potentiating adoptive cell therapy using synthetic IL-9 receptors

Nature(2022)10.1038/s41586-022-04801-2

N/A

0DataRank · unranked

117 citations

Mikko Siurala, Leon Su, Mito Tariveranmoshabad, Lora K. Picton, Pranali Ravikumar +18 more

Rigorous benchmarking of T cell receptor repertoire profiling methods for cancer RNA sequencing

medRxiv(2022)10.1101/2022.03.31.22273249

N/A

0DataRank · unranked

1 citations

Theodore S. Nowicki, Katie M. Campbell, Dandan Peng, Anish Nagareddy, Yu-Ning Huang +10 more

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

medRxiv(2022)10.1101/2022.09.13.22279873

N/A

0DataRank · unranked

0 citations

Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent +20 more

T Cells as the Future of Cancer Therapy

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0022

N/A

0DataRank · unranked

7 citations

Antoni Ribas

How Did We Get a COVID-19 Vaccine in Less Than 1 Year?

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0079

N/A

0DataRank · unranked

16 citations

Elizabeth M. Jaffee, Nicholas J.H. Warren, Gypsyamber DʼSouza, Antoni Ribas, E. John Wherry

Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100419

N/A

0DataRank · unranked

18 citations

Candace C. Liu, Erin McCaffrey, Rashmi Kumar, Theodore S. Nowicki, David W. Dawson +6 more

Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1847

N/A

0DataRank · unranked

25 citations

Zev A. Wainberg, Anisha B. Patel, Milan J. Anadkat, Salomon M. Stemmer, Einat Shacham‐Shmueli +5 more

At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0008

N/A

0DataRank · unranked

28 citations

Antoni Ribas, Marina Chiara Garassino

Antoni Ribas

Indexed papers

Top data-sharing exemplar

Papers